Rifampin na ujauzito

Imeboreshwa:

Tafiti nyingi zimechunguza matibabu ya Kifua kikuu kwa kutumia dawa hii na zote zilihitimisha kuwa rifampin haikuwa na uwezo wa kusababisha madhaifu ya kimaumbile kwa kijusi tumboni na hivyo kupendekeza dawa hii na isoniazid kutumika katika matibabu ya TB. Tafiti zingine zingine pia zimeonyesha kutokuwepo kwa madhara kwa kichanga.Endapo itatumika kwa watoto, inashauriwa kutumia dawa hii pamoja na vitamin K ili kumkinga kichanga kuumwa ugonjwa kuvuja damu wenye jina la hemorrhagic disease of the newborn.

Ushauri dhidi ya matumizi kwa mama mjamzito

Inapatana na ujauzito

Inapatana na ujauzito, ina maana gani?

Uzoefu wa matumizi kwa binadamu kuhusu dawa hii au dawa zingine zilizo kundi moja au zenye kufanya kazi kwa utaratibu unaofanana, zinatosha kuonyesha kuwa, madhara kwa kichanga tumboni ni madogo sana au hakuna kabisa. Tafiti za uzazi kwa wanyama hazina uhalisia kwa binadamu.

Ushauri wa matumizi kwa mama anayenyonyesha

Inapatana na unyonyeshaji

Inapatana na unyonyeshaji, ina maana gani?

Kiasi kidogo cha dawa hii kinawezekana kuingia kwenye maziwa ya mama, kiasi hiki hakina mashiko ya kusababisha sumu kwa kichanga anayenyonya. Dawa hii haitarajiwi kusababisha madhara kwa kichanga anayenyonya maziwa ya mama anayetumia dawa hii.

ULY Clinic inakushauri uwasiliane na daktari wako siku zote kabla ya kufanya maamuzi yanayohusisha afya yako

Wasiliana na daktari wa ULY Clinic kwa ushauri na Tiba au kuandikiwa dawa kwa kutumia namba za simu au Kubonyeza Pata tiba chini ya tovuti hii.

Imeandikwa:

Orodha kuu

2 Aprili 2026, 11:41:58

Rejea za dawa

Snider DE Jr, et al. Treatment of tuberculosis during pregnancy. Am Rev Respir Dis. 1980;122:65–79.
American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis. 1986;134:355–63.
Medchill MT, Gillum M. Diagnosis and management of tuberculosis during pregnancy. Obstet Gynecol Surv. 1989;44:81–4.
Shneerson JM, Frances RS. Ethambutol in pregnancy: foetal exposure. Tubercle. 1979;60:167–9.
Kingdon JCP, Kennedy DH. Tuberculosis meningitis in pregnancy. Br J Obstet Gynaecol. 1989;96:233–5.
Eggermont E, et al. Haemorrhagic disease of the newborn in the offspring of rifampicin and isoniazid treated mothers. Acta Paediatr Belg. 1976;29:87–90.
Tuchmann-Duplessis H, Mercier-Parot L. Influence d’un antibiotique, la rifampicine, sur le developpement prenatal des ronguers. C R Acad Sci (d) (Paris). 1969;269:2147–9. As cited in Shepard TH. Catalog of Teratogenic Agents. 6th ed. Baltimore, MD: The Johns Hopkins University Press; 1989. p. 558–9.
Product information. Rifadin. Hoechst Marion Roussel; 2000.
Reimers D. Missbildungen durch Rifampicin. Bericht ueber 2 faelle von normaler fetaler entwicklung nach rifampicin therapie in der fruehschwangerschaft. Munchen Med Wochenschr. 1971;113:1690.
Warkany J. Antituberculous drugs. Teratology. 1979;20:133–8.
Steen JSM, Stainton-Ellis DM. Rifampicin in pregnancy. Lancet. 1977;2:604–5.
Rocker I. Rifampicin in early pregnancy. Lancet. 1977;2:48.
Kenny MT, Strates B. Metabolism and pharmacokinetics of the antibiotic rifampin. Drug Metab Rev. 1981;12:159–218.
Holdiness MR. Transplacental pharmacokinetics of the antituberculosis drugs. Clin Pharmacokinet. 1987;13:125–9.
Gupta KC, Ali MY. Failure of oral contraceptives with rifampicin. Med J Zambia. 1980;15:23.
Vorherr H. Drug excretion in breast milk. Postgrad Med J. 1974;56:97–104.
Lenzi E, Santuari S. Preliminary observations on the use of a new semi-synthetic rifamycin derivative in gynecology and obstetrics. Atti Accad Lancisiana Roma. 1969;13(Suppl 1):87–94. As cited in Snider DE Jr, Powell KE. Should women taking antituberculosis drugs breastfeed? Arch Intern Med. 1984;144:589–90.
Snider DE Jr, Powell KE. Should women taking antituberculosis drugs breastfeed? Arch Intern Med. 1984;144:589–90.
Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776–89.